Thank you, Mr. Speaker. Yeah, I -- and I know that the department and -- whenever we're looking to bring a vaccine into public funded, there's a bit of a debate, you know, about most vaccines that save us money in healthcare costs in the long term if they prevent hospitalizations we save money in the long term. And with shingles, in this case we would save people a lot of pain. I'm just wondering if the department has any evidence that -- or has done any of the research about whether extending this vaccine to everyone would actually save the health system money? Thank you, Mr. Speaker.
Rylund Johnson on Question 994-19(2): Shingles Vaccine
In the Legislative Assembly on March 7th, 2022. See this statement in context.
Question 994-19(2): Shingles Vaccine
Oral Questions
March 7th, 2022
Page 3798
See context to find out what was said next.